Memantine as an Augmentation Therapy for Anxiety Disorders

Memantine as an Augmentation Therapy for Anxiety Disorders

Objective. Glutamate, an excitatory neurotransmitter in the central nervous system (CNS), may play a role in the development of anxiety. Memantine partially blocks N-methyl-D-aspartate (NMDA) receptors' glutamate channels located in the CNS. This paper evaluates memantine as an augmentation the...

Full description

Bibliographic Details
Main Authors:	Thomas L. Schwartz, Umar A. Siddiqui, Shafi Raza
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	Case Reports in Psychiatry
Online Access:	http://dx.doi.org/10.1155/2012/749796

Similar Items

Memantine as an augmentation therapy in obsessive–Compulsive disorder
by: Parul Gupta, et al.
Published: (2019-01-01)

Efficacy of Memantine as Adjunct Therapy for Autism Spectrum Disorder in Children Aged <14 Years
by: Mojgan Karahmadi, et al.
Published: (2018-01-01)

Memantine Disrupts Motor Coordination through Anxiety-like Behavior in CD1 Mice
by: Belozor, O.S, et al.
Published: (2022)

Study of the effect of memantine therapy on the treatment of dyslexia in children
by: Mojgan Karahmadi, et al.
Published: (2017-01-01)

Effectiveness of Memantine in Improvement of Cognitive Deficits in Specific Learning Disorder
by: Elham Ahmadi Zahrani, et al.
Published: (2016-12-01)

Memantine: Reality and Potentiality
by: Rita Moretti M.D., et al.
Published: (2008-01-01)

Memantine: Reality and Potentiality
by: Rodolfo M. Antonello, et al.
Published: (2008-01-01)

Crystal structure of memantine–carboxyborane
by: Theppawut I. Ayudhya, et al.
Published: (2019-05-01)

An Experimental Study to Evaluate the Effect of Memantine in Animal Models of Anxiety in Swiss Albino Mice
by: HARISH G BAGEWADI, et al.
Published: (2015-08-01)

Is Memantine Effective as an NMDA-Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
by: Tetsuro Kikuchi
Published: (2020-07-01)

An open-label trial of memantine in treatment-resistant obsessive-compulsive disorder
by: Ajay Kumar Bakhla, et al.
Published: (2013-01-01)

Memantine ameliorates migraine headache
by: Sundar Shanmugam, et al.
Published: (2019-01-01)

An Open-Label Trial of Memantine for Cognitive Impairment in Patients with Posttraumatic Stress Disorder
by: Sriram Ramaswamy, et al.
Published: (2015-01-01)

The efficacy of memantine in the treatment of civilian posttraumatic stress disorder: an open-label trial
by: Hiroaki Hori, et al.
Published: (2021-01-01)

Assessing the synergy between cholinomimetics and memantine as augmentation therapy in Cognitive Impairment in Schizophrenia. A virtual human patient trial using Quantitative Systems Pharmacology
by: Hugo eGeerts, et al.
Published: (2015-09-01)

D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis.
by: Paul-Christian Bürkner, et al.
Published: (2017-01-01)

Effect of Renal Impairment on the Pharmacokinetics of Memantine
by: Takashi Moritoyo, et al.
Published: (2012-01-01)

Tackling Negative Symptoms of Schizophrenia with Memantine
by: Antonios Paraschakis
Published: (2014-01-01)

Anxiety disorders therapy in general practice
by: L. A. Ivanova
Published: (2017-09-01)

Memantine, Donepezil, or Combination Therapy—What is the best therapy for Alzheimer’s Disease? A Network Meta‐Analysis
by: Jiaxun Guo, et al.
Published: (2020-11-01)

A potential combination therapy for traumatic brain injury: 17beta-estradiol and memantine
by: Lamprecht, Michael Robert
Published: (2015)

Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
by: Giambattista Marotta, et al.
Published: (2020-09-01)

Is Memantine a Potential Therapeutic for Rett Syndrome?
by: Olivia eBello, et al.
Published: (2013-12-01)

Determination of memantine by high performance liquid chromatographic
by: Yi-Ching Kuo, et al.
Published: (2009)

Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders
by: Leung-Wah Yick, et al.
Published: (2020-08-01)

Memantine-induced Myoclonus in a Patient with Alzheimer Disease
by: Aditya A. Murgai, et al.
Published: (2015-08-01)

Hydrolytic Stability of New Amino Acids Analogues of Memantine
by: Aleksandra Tencheva, et al.
Published: (2020-09-01)

Management of moderate to severe Alzheimer’s disease: Focus on memantine
by: Evangelyn Dominguez, et al.
Published: (2011-12-01)

Memantine for the treatment of frontotemporal dementia: a meta-analysis
by: Kishi T, et al.
Published: (2015-11-01)

Update on the use of memantine in Alzheimer&rsquo;s disease
by: Robert J van Marum
Published: (2009-03-01)

Dual Action of Memantine in Alzheimer Disease: A Hypothesis
by: Tzong-Yuan Wu, et al.
Published: (2009-09-01)

Effects of memantine on the excitation-inhibition balance in prefrontal cortex
by: Nadezhda V. Povysheva, et al.
Published: (2016-12-01)

Neuroenhancement of Exposure Therapy in Anxiety Disorders
by: Stefan G. Hofmann, et al.
Published: (2015-07-01)

Memantine improves memory and hippocampal proliferation in adult male rats
by: Maha Elbeltagy, et al.
Published: (2021-06-01)

Systematic Review and Meta-Analysis of Combination Therapy with Cholinesterase Inhibitors and Memantine in Alzheimer’s Disease and Other Dementias
by: Taim Muayqil, et al.
Published: (2012-11-01)

EXPERIENCE WITH THE DRUG MEMANTINE IN PATIENTS WITH FOCAL EPILEPSY AND COGNITIVE IMPAIRMENT
by: Yu. V. Solomatin, et al.
Published: (2016-05-01)

Treatment of alcohol dependence in patients with co-morbid major depressive disorder – predictors for the outcomes with memantine and escitalopram medication
by: Lönnqvist Jouko, et al.
Published: (2008-10-01)

Effect of Memantine on Overactive Detrusor in Rats With Spinal Cord Injury
by: Cüneyd Özkürkçügil, et al.
Published: (2010-05-01)

Memantine Attenuates Alzheimer's Disease-Like Pathology and Cognitive Impairment.
by: Xiaochuan Wang, et al.
Published: (2015-01-01)

Memantine has no effect on KATP channels in pancreatic β cells
by: Ryota Imai, et al.
Published: (2018-08-01)